The DEVOTE trial compared cardiovascular safety in two basal insulins; insulin degludec was found to have additional benefits.

Results from the REMOVAL trial revealed reduction in the risk of cardiovascular disease among other benefits with metformin in type 1 diabetes patients.

Results from two ODYSSEY studies indicate the favorable lipid lowering effects of Alirocumab, a PCSK9 inhibitor, in type 2 diabetes patients can potentially reduce the risk of cardiovascular disease.

A 78-year old patient with a 15-year history of type 2 diabetes arrives in your office for a check-up. He suffers from stage 3 chronic kidney disease and lives alone. From previous visits you have learned he has very few support services. What would be a realistic A1C treatment target for this individual? A. A1C 6.0-6.5% B. A1C 7.5-8.0% C. A1C 8.5-10.0% D. A1C 10.5-11% Follow the link to see the correct answer!

Would you consider using a combination of SGLT-2 Inhibitor along with an GLP-1 Agonist, now or in the future? Follow the link to see how you and your colleagues compare!

MedAngel ONE is the best solution to monitor and protect temperature sensitive medications like insulin. Continuous monitoring and logging ensures that you and your patients can always can always see beyond doubt if your medications were stored properly. It supports hundreds of FDA approved medications and adapts the smart alerts to them. If a dangerous temperature is approached or exceeded, the app will alert you immediately. Read on for details and for a special discount + Free shipping Use code: Med10.

When it comes to antidiabetic therapies, professionals should be aware of safety concerns with concentrated insulin formulations, metformin and renal function, and SGLT-2 inhibitors and DKA. See the breakdown of these safety issues by Tom Palma, RPh, MS, BCPS, and Greg Wiggers, PharmD, PhD, plus exclusive commentary by DIC Advisory Board member Dr. George Bakris.

Low serum magnesium partly mediated through insulin resistance

Is procedure worth associated acute pancreatitis or spontaneous over-inflation?

Arrhythmia incidents differ in nocturnal and diurnal hypoglycemic patients.